A convenient prognostic score consisting of the Glasgow prognostic score and serum lactate dehydrogenase predicts clinical outcome in patients with diffuse large B-cell lymphoma

Leuk Lymphoma. 2016 Oct;57(10):2460-3. doi: 10.3109/10428194.2016.1143940. Epub 2016 Feb 17.

Authors

Yusuke Kanemasa¹, Tatsu Shimoyama¹, Yuki Sasaki², Takeshi Sawada¹, Yasushi Omuro¹, Tsunekazu Hishima³, Yoshiharu Maeda¹

Affiliations

¹ a Department of Medical Oncology , Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , Tokyo , Japan ;
² b Department of Clinical Research Support , Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital , Tokyo , Japan ;
³ c Department of Pathology , Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital , Tokyo , Japan.

PMID: 26886828
DOI: 10.3109/10428194.2016.1143940

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Albumins / analysis
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols
C-Reactive Protein / analysis
Cyclophosphamide
Doxorubicin
Female
Humans
Lactate Dehydrogenases / blood*
Lymphoma, Large B-Cell, Diffuse / blood
Lymphoma, Large B-Cell, Diffuse / diagnosis*
Lymphoma, Large B-Cell, Diffuse / drug therapy
Lymphoma, Large B-Cell, Diffuse / mortality
Male
Middle Aged
Patient Outcome Assessment*
Predictive Value of Tests
Prednisone
Prognosis
Research Design
Rituximab
Survival Analysis
Vincristine

Substances

Albumins
Antibodies, Monoclonal, Murine-Derived
R-CHOP protocol
Rituximab
Vincristine
Doxorubicin
Cyclophosphamide
C-Reactive Protein
Lactate Dehydrogenases
Prednisone